secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-01-31T23:59:59+00:00
Accession:  0001493152-25-004490
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions plans multilingual upgrade for drug screening system, aims to reach 4B users
--------------------------------------------------------------------------------

- Multilingual upgrade will support languages across Americas, Europe, Asia Pacific, and Middle East, accessible to over 4 billion speakers worldwide.
- Supports planned 2025 entry into US market following FDA 510(k) submission in December 2024.
- Company has existing presence in 19 countries; targets safety-critical industries like construction, mining, and transport.
- Drug screening market projected to reach approximately $8 billion globally by 2030.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225004490/0001493152-25-004490-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225004490/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004490

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer